Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model
Drug Delivery and Translational Research · 2025-06 · 15 (6) · 1985-1993
DOI: 10.1007/s13346-024-01715-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 14.10.2024. Verfasst von Caren van Kammen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanomedicine, LAB CDL Research, UMC Utrecht, Utrecht, The Netherlands. c.m.vankammen@umcutrecht.nl. Hauptthemen laut MEDLINE: Placenta, Nanoparticles, Maternal-Fetal Exchange, Lipids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Medication use during pregnancy poses risks to both the mother and the fetus. These risks include an elevated potential for fetotoxicity due to placental drug transport. Nanomedicines offer a promising solution by potentially preventing trans-placental passage. Targeted nanomedicines could enhance safety and efficacy in treating maternal or placental pathophysiology. Our study investigates placental transfer kinetics of targeted lipid nanoparticles (LNPs) in an ex vivo human placenta cotyledon perfusion model. We collected human placentas for dual-side ex vivo placental perfusions. Targeted LNPs with a fluorescence tag were introduced into the maternal circuit of each placenta. To establish if there was trans-placental passage of LNPs to the fetal circuit, we collected samples from maternal and fetal circuits throughout the six hours of the perfusion. We determined the fluorescence signal using a multi-mode microplate reader and Multiphoton microscopy to localize the LNPs in the placenta tissue. Data from perfused placenta tissue showed no significant transfer of the fluorescently labeled LNPs across the placental barrier to the fetal circuit. Localization of targeted LNPs in tissue samples is mainly observed in the maternal blood space of the placenta. Our results suggest that targeted LNPs present a promising strategic approach to prevent trans-placental passage to the fetus. Our future perspectives involve investigating the efficacy of targeted LNPs as well as loading targeted LNPs with nucleic acid-based therapeutics to investigate their therapeutic potential. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nanomedicine, LAB CDL Research, UMC Utrecht, Utrecht, The Netherlands. c.m.vankammen@umcutrecht.nl.
- Department of Pharmacy, Division of Pharmacology and Toxicology, Radboud UMC, Nijmegen, The Netherlands.
- Department of Genetics and Cell Biology, Maastricht University, Maastricht, The Netherlands.
- Interdisciplinary Centre for Clinical Research IZKF, University Hospital RWTH Aachen, Aachen, Germany.
- Department of Nanomedicine, LAB CDL Research, UMC Utrecht, Utrecht, The Netherlands.
- Department of Obstetrics, Wilhemina Children's Hospital, UMC Utrecht, Utrecht, The Netherlands.
ORCID-Profile: Caren van Kammen
Förderung
- ZonMw
Zitieren
APA
van Kammen, C., van Hove, H., Kapsokalyvas, D., Greupink, R., Schiffelers, R., Lely, T., & Terstappen, F. (2025). Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model. Drug Delivery and Translational Research, 15(6), 1985-1993. https://doi.org/10.1007/s13346-024-01715-6
Vancouver
van Kammen C, van Hove H, Kapsokalyvas D, Greupink R, Schiffelers R, Lely T, et al. Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model. Drug Delivery and Translational Research. 2025;15(6):1985-1993. doi:10.1007/s13346-024-01715-6
BibTeX
@article{vanKammen2025,
author = {van Kammen, Caren and van Hove, Hedwig and Kapsokalyvas, Dimitrios and Greupink, Rick and Schiffelers, Raymond and Lely, Titia and Terstappen, Fieke},
title = {Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model},
journal = {Drug Delivery and Translational Research},
year = {2025},
volume = {15},
number = {6},
pages = {1985--1993},
doi = {10.1007/s13346-024-01715-6}
}
EUVIMED